28.09
1.96%
+0.54
After Hours:
28.09
Progyny Inc stock is currently priced at $28.09, with a 24-hour trading volume of 1.26M.
It has seen a +1.96% increased in the last 24 hours and a -14.23% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $27.34 pivot point. If it approaches the $28.49 resistance level, significant changes may occur.
Previous Close:
$27.55
Open:
$27.54
24h Volume:
1.26M
Market Cap:
$2.67B
Revenue:
$1.09B
Net Income/Loss:
$62.04M
P/E Ratio:
57.33
EPS:
0.49
Net Cash Flow:
$185.17M
1W Performance:
+2.03%
1M Performance:
-14.23%
6M Performance:
-12.76%
1Y Performance:
-20.85%
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212 888 3124
Address
1359 Broadway, New York, NY
Progyny Inc Stock (PGNY) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-03-24 | Initiated | Barclays | Overweight |
Sep-27-23 | Initiated | Canaccord Genuity | Buy |
May-22-23 | Initiated | BTIG Research | Buy |
Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
Sep-07-22 | Initiated | Truist | Buy |
Dec-02-21 | Initiated | Jefferies | Buy |
Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
Sep-30-21 | Initiated | Berenberg | Buy |
Aug-12-21 | Initiated | Barclays | Overweight |
Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
Apr-29-21 | Resumed | JP Morgan | Overweight |
Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
Jul-01-20 | Initiated | SVB Leerink | Outperform |
Jun-02-20 | Initiated | Guggenheim | Buy |
Nov-19-19 | Initiated | Citigroup | Buy |
Nov-19-19 | Initiated | Goldman | Buy |
Nov-19-19 | Initiated | JP Morgan | Overweight |
Nov-19-19 | Initiated | Piper Jaffray | Overweight |
Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
Progyny (NASDAQ:PGNY) PT Lowered to $37.00 - MarketBeat
MarketBeat
Jump Financial LLC Sells 36772 Shares of Progyny, Inc. (NASDAQ:PGNY) - Defense World
Defense World
Progyny, Inc. (NASDAQ:PGNY) Holdings Trimmed by Jump Financial LLC - MarketBeat
MarketBeat
Victory Capital Management Inc. Purchases 8670 Shares of Progyny, Inc. (NASDAQ:PGNY) - Defense World
Defense World
Cantor Fitzgerald Reaffirms Overweight Rating for Progyny (NASDAQ:PGNY) - MarketBeat
MarketBeat
Progyny, Inc. (NASDAQ:PGNY) Shares Acquired by Principal Financial Group Inc. - MarketBeat
MarketBeat
Progyny Inc Stock (PGNY) Financials Data
Progyny Inc (PGNY) Revenue 2024
PGNY reported a revenue (TTM) of $1.09 billion for the quarter ending December 31, 2023, a +38.34% rise year-over-year.
Progyny Inc (PGNY) Net Income 2024
PGNY net income (TTM) was $62.04 million for the quarter ending December 31, 2023, a +104.35% increase year-over-year.
Progyny Inc (PGNY) Cash Flow 2024
PGNY recorded a free cash flow (TTM) of $185.17 million for the quarter ending December 31, 2023, a +140.00% increase year-over-year.
Progyny Inc (PGNY) Earnings per Share 2024
PGNY earnings per share (TTM) was $0.62 for the quarter ending December 31, 2023, a +106.67% growth year-over-year.
Progyny Inc Stock (PGNY) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Payson Norman | Director |
Nov 23 '24 |
Sale |
56.29 |
200 |
11,258 |
580,656 |
Sturmer Michael E | PRESIDENT |
May 01 '24 |
Sale |
31.95 |
4,515 |
144,254 |
380,038 |
Livingston Mark S. | CHIEF FINANCIAL OFFICER |
Apr 01 '24 |
Option Exercise |
3.95 |
20,627 |
81,477 |
72,875 |
Schlanger David J | Executive Chairman |
Apr 01 '24 |
Option Exercise |
3.95 |
1,000 |
3,950 |
87,312 |
Livingston Mark S. | CHIEF FINANCIAL OFFICER |
Apr 01 '24 |
Sale |
37.62 |
11,165 |
419,979 |
50,119 |
Sturmer Michael E | PRESIDENT |
Apr 01 '24 |
Sale |
37.60 |
6,395 |
240,452 |
384,553 |
Schlanger David J | Executive Chairman |
Apr 01 '24 |
Sale |
37.52 |
1,000 |
37,522 |
83,631 |
Schlanger David J | Executive Chairman |
Mar 27 '24 |
Option Exercise |
3.95 |
71,272 |
281,845 |
157,584 |
Schlanger David J | Executive Chairman |
Mar 27 '24 |
Sale |
37.80 |
71,272 |
2,694,267 |
86,312 |
Schlanger David J | Executive Chairman |
Mar 26 '24 |
Option Exercise |
3.95 |
305 |
1,206 |
86,617 |
About Progyny Inc
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption expenses for clients and their employees. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Cap:
|
Volume (24h):